Ironwood Pharmaceuticals (IRWD) Total Liabilities (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Total Liabilities data on file, last reported at $434.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 32.81% year-over-year to $434.6 million; the trailing twelve-month figure through Mar 2026 stood at $434.6 million (up 32.81% YoY), and the FY2025 full-year result was $396.9 million, up 13.11% from the prior year.
• Total Liabilities grew to $434.6 million in Q1 2026, from $396.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.2 billion in Q1 2023 to a low of $327.2 million in Q1 2025.
• A 5-year average of $613.3 million and a median of $438.8 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 80.76% in 2022 and slumped 62.02% in 2024, its largest moves.
• Tracing IRWD's Total Liabilities over 5 years: stood at $1.1 billion in 2022, then plunged by 57.2% to $471.1 million in 2023, then dropped by 25.51% to $350.9 million in 2024, then climbed by 13.11% to $396.9 million in 2025, then increased by 9.49% to $434.6 million in 2026.
• Business Quant data shows IRWD's Total Liabilities at $434.6 million in Q1 2026, $396.9 million in Q4 2025, and $396.1 million in Q3 2025.